Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®

Summary

Primary Objective: \- To assess the total metabolic effect ratios of a new insulin glargine formulation versus Lantus® Secondary Objectives: * To assess the exposure ratios of a new insulin glargine formulation versus Lantus® * To compare the duration of action of a new insulin glargine formulation versus Lantus® * To explore the dose response and dose exposure relationship of a new insulin glargine formulation * To assess the safety and tolerability of a new insulin glargine formulation

Timeline

Start

2010-08

Primary completion

2010-11

Completion

2010-12

Drugs

Indications